IMPROVING PULMONARY TUBERCULOSIS (TB) OUTCOMES: Investigating novel adjunctive immunotherapies and addressing HIV-TB co-infection in Papua, Indonesia

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1016567

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Tuberculosis remains a major regional and global problem, especially in resource-limited settings such as Australia’s northern neighbours. Three key challenges are to make TB cure easier by shortening treatment, improve HIV-TB co-infection management, and tackle drug resistance. We address these issues in Indonesia’s Papua Province, where we are testing whether simple supplements given with TB treatment might accelerate cure; improving HIV care in people with TB, and detecting drug-resistant TB.

Funded Activity Details

Start Date: 01-01-2011

End Date: 01-01-2015

Funding Scheme: Early Career Fellowships

Funding Amount: $217,846.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Pacific Peoples Health

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

adjunctive therapies | drug resistance | human immunodeficiency virus (HIV) | immune response | nitric oxide | pulmonary infection | treatment outcomes | tuberculosis

Related Links